CTSA Postdoctoral T32 at the University of Alabama at Birmingham
Project Number1T32TR004770-01
Contact PI/Project LeaderHIDALGO, BERTHA
Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
Project Summary/Abstract
Dissemination and implementation (D&I) science is the study of how to effectively translate research findings
into practice and policy. By integrating dissemination and implementation science into the clinical and
translational science spectrum, researchers and practitioners can better understand the factors that influence
the uptake of evidence-based practices and develop strategies to overcome barriers to implementation.
However, in the Deep South, there is a critical shortage of professionals broadly . This limits the ability of
researchers and practitioners to develop and implement effective interventions to address health disparities
and improve health equity. Hence the objective of this proposed program is to launch the first T32 postdoctoral
training program dedicated to the integration of dissemination and implementation science within and across
the translational science spectrum. We seek applications from MDs, PhDs, and doctoral candidates, from a
wide range of clinical and scientific disciplines, and diverse personal backgrounds. The proposed program will
take full advantage of the stellar resources of the Clinical and Translational Science Center at the University of
Alabama at Birmingham and related Deep South Partner Network. The program’s aims are to: [1] Identify,
recruit, and train a diverse cadre of postdoctoral scientists with the knowledge, skills, and experience
to become independent investigators who will continue to expand the field of dissemination and
implementation; [2] Establish a rigorous, innovative training program in dissemination and
implementation science to facilitate nuanced integration of D&I domains within and across the
translational science spectrum; [3] Enhance the integration of D&I and clinical and translational
science by embracing health equity as a critical, key focus area of scientific advancement. This
proposal has 4 distinguishing characteristics: (1) Integration with an NCATS-supported Clinical and
Translational Science Hub at UAB and Partner Network comprised of 11 institutions across the Deep South of
the US; (2) D&I mentors and resources representing an extraordinary breadth of disciplines across the
translational spectrum; (3) A focus on D&I research centered in addressing health inequities in the Deep
South, and (4) An training design anchored in diversity, equity, inclusion, and accessibility. Didactic
components leverage coursework developed by UAB and Partner Network investigators, and additional UAB
programs that have trained generations of scientists in clinical investigation, translational science, and public
health research methods. Training duration will be 2 years. We will have 5 slots per year. Successful
candidates must show evidence of a strong commitment to D&I science a commitment to health equity
research. Trainee progress will be monitored and evaluated by the Program Directors, mentors, and advisory
committees.
Public Health Relevance Statement
Project Narrative
Dissemination and implementation (D&I) science is the study of how to effectively and efficiently spread
evidence-based practices and interventions to the people who can benefit from them. It is important to
integrate this type of science into the clinical and translational science spectrum because it helps ensure that
new treatments and therapies are not just developed, but also effectively implemented and used in real-world
settings. This can ultimately lead to improved health outcomes for individuals and communities. This
postdoctoral training program will train new scientists in D&I science so we can take better care of people and
improve inequities in health and health outcomes.
National Center for Advancing Translational Sciences
CFDA Code
350
DUNS Number
063690705
UEI
YND4PLMC9AN7
Project Start Date
01-May-2024
Project End Date
30-April-2029
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$444,271
Direct Costs
$414,140
Indirect Costs
$30,131
Year
Funding IC
FY Total Cost by IC
2024
National Center for Advancing Translational Sciences
$444,271
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1T32TR004770-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1T32TR004770-01
Patents
No Patents information available for 1T32TR004770-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1T32TR004770-01
Clinical Studies
No Clinical Studies information available for 1T32TR004770-01
News and More
Related News Releases
No news release information available for 1T32TR004770-01
History
No Historical information available for 1T32TR004770-01
Similar Projects
No Similar Projects information available for 1T32TR004770-01